The World Health Organization has temporarily halted studying hydroxychloroquine as a potential Covid-19 treatment in its Solidarity Trial due to safety concerns, WHO Director-General Tedros Adhanom Ghebreyesus said during a briefing in Geneva on Monday.
The decision was made after an observational study was published in the medical journal The Lancet on Friday, which described how seriously ill Covid-19 patients who were treated with hydroxychloroquine and chloroquine were more likely to die.
The post WHO temporarily pauses studying hydroxychloroquine due to safety concerns appeared first on Madison Free Clinic.
Mondays 9-noon (Office only)
Tuesdays 9-noon and 3-6 p.m. (Office only)
Wednesdays 9-noon (Office only)
Thursdays 9-noon (Office) and 6-7 p.m. (Clinic)
Fri. 9-noon (Office) and 9-2 (Clinic)
All Rights Reserved